DFTX
NASDAQ · Pharmaceuticals
Definium Therapeutics Inc
$22.05
-1.15 (-4.96%)
Open$22.86
Previous Close$23.20
Day High$22.86
Day Low$21.31
52W High$26.25
52W Low$6.03
Volume—
Avg Volume1.57M
Market Cap2.53B
P/E Ratio—
EPS$-2.06
SectorPharmaceuticals
Analyst Ratings
Strong Buy
22 analysts
Price Target
+108.6% upside
Current
$22.05
$22.05
Target
$46.00
$46.00
$39.37
$46.00 avg
$57.04
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 685.27M | 628.04M | 535.94M |
| Net Income | 136.42M | 119.21M | 84.03M |
| Profit Margin | 19.9% | 19.0% | 15.7% |
| EBITDA | 222.00M | 198.31M | 161.40M |
| Free Cash Flow | 100.39M | 95.21M | 82.42M |
| Rev Growth | -7.8% | +7.1% | -9.9% |
| Debt/Equity | 0.71 | 0.57 | 0.52 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |